HLB Genex Statistics

Total Valuation

HLB Genex has a market cap or net worth of KRW 81.87 billion. The enterprise value is 93.90 billion.

Market Cap	81.87B
Enterprise Value	93.90B

Important Dates

The last earnings date was Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

HLB Genex has 29.14 million shares outstanding. The number of shares has increased by 22.35% in one year.

Current Share Class	29.14M
Shares Outstanding	29.14M
Shares Change (YoY)	+22.35%
Shares Change (QoQ)	+219.92%
Owned by Insiders (%)	12.56%
Owned by Institutions (%)	2.24%
Float	18.56M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.00
PB Ratio	1.82
P/TBV Ratio	4.03
P/FCF Ratio	30.50
P/OCF Ratio	22.56
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 26.12, with an EV/FCF ratio of 34.98.

EV / Earnings	-28.66
EV / Sales	2.29
EV / EBITDA	26.12
EV / EBIT	n/a
EV / FCF	34.98

Financial Position

The company has a current ratio of 0.77, with a Debt / Equity ratio of 0.94.

Current Ratio	0.77
Quick Ratio	0.66
Debt / Equity	0.94
Debt / EBITDA	8.69
Debt / FCF	15.71
Interest Coverage	0.05

Financial Efficiency

Return on equity (ROE) is -6.87% and return on invested capital (ROIC) is 0.38%.

Return on Equity (ROE)	-6.87%
Return on Assets (ROA)	0.29%
Return on Invested Capital (ROIC)	0.38%
Return on Capital Employed (ROCE)	0.76%
Revenue Per Employee	546.00M
Profits Per Employee	-43.68M
Employee Count	75
Asset Turnover	0.39
Inventory Turnover	4.10

Taxes

In the past 12 months, HLB Genex has paid 1.10 billion in taxes.

Income Tax	1.10B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -29.13% in the last 52 weeks. The beta is -0.00, so HLB Genex's price volatility has been lower than the market average.

Beta (5Y)	-0.00
52-Week Price Change	-29.13%
50-Day Moving Average	3,008.80
200-Day Moving Average	3,356.00
Relative Strength Index (RSI)	40.54
Average Volume (20 Days)	47,854

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HLB Genex had revenue of KRW 40.95 billion and -3.28 billion in losses. Loss per share was -116.43.

Revenue	40.95B
Gross Profit	15.52B
Operating Income	479.33M
Pretax Income	-1.44B
Net Income	-3.28B
EBITDA	4.85B
EBIT	479.33M
Loss Per Share	-116.43

Full Income Statement

Balance Sheet

The company has 38.26 billion in cash and 42.17 billion in debt, giving a net cash position of -3.92 billion or -134.51 per share.

Cash & Cash Equivalents	38.26B
Total Debt	42.17B
Net Cash	-3.92B
Net Cash Per Share	-134.51
Equity (Book Value)	44.88B
Book Value Per Share	1,260.08
Working Capital	-15.97B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.63 billion and capital expenditures -944.90 million, giving a free cash flow of 2.68 billion.

Operating Cash Flow	3.63B
Capital Expenditures	-944.90M
Free Cash Flow	2.68B
FCF Per Share	92.14

Full Cash Flow Statement

Margins

Gross margin is 37.90%, with operating and profit margins of 1.17% and -8.00%.

Gross Margin	37.90%
Operating Margin	1.17%
Pretax Margin	-3.53%
Profit Margin	-8.00%
EBITDA Margin	11.85%
EBIT Margin	1.17%
FCF Margin	6.56%

Dividends & Yields

HLB Genex does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.35%
Shareholder Yield	-22.35%
Earnings Yield	-4.00%
FCF Yield	3.28%

Stock Splits

The last stock split was on March 19, 2018. It was a forward split with a ratio of 2.

Last Split Date	Mar 19, 2018
Split Type	Forward
Split Ratio	2

Scores

HLB Genex has an Altman Z-Score of 0.82 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.82
Piotroski F-Score	7